Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke

• Published in: Heart rhythm Vol. 18; no. 3; pp. 338 - 346
• Main Authors: Al-Gibbawi, Mounir, Ayinde, Hakeem O., Bhatia, Neal K., El-Chami, Mikhael F., Westerman, Stacy B., Leon, Angel R., Shah, Anand D., Patel, Anshul M., De Lurgio, David B., Tompkins, Christine M., Lloyd, Michael S., Merchant, Faisal M., Kiani, Soroosh
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2021
• Subjects: Aged; Anticoagulants - therapeutic use; Atrial fibrillation; Atrial Fibrillation - complications; Atrial Fibrillation - diagnosis; Atrial Fibrillation - drug therapy; Burden; CHA2DS2-VASc; Duration; Electrocardiography, Ambulatory - instrumentation; Equipment Design; Feasibility Studies; Female; Follow-Up Studies; Heart Rate - physiology; Humans; Incidence; Ischemic Stroke - epidemiology; Ischemic Stroke - etiology; Ischemic Stroke - prevention & control; Male; Retrospective Studies; Risk Assessment - methods; Risk factors; Stroke; United States - epidemiology; United States; Stroke; Duration; Burden; Atrial fibrillation; CHA2DS2-VASc; Risk factors; CHADS-VASc

Wider availability of continuous rhythm monitoring has made feasible the incorporation of metrics of atrial fibrillation (AF) burden and duration into the decision to initiate anticoagulation. However, the relationship between thresholds of burden and duration and underlying risk factors at which an...